| ²é¿´: 397 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
[½»Á÷]
Çó·Òë³ÉÖÐÎÄ
|
|||
|
To date, different mutations have been reported that result in a complete deficiency, including: two deletions (295¨C298delTCAT and 1897delC), one splice-site mutation (IVS14+IG>A), four missense mutations (85T>C, 703C>T, 2657G>A, and 2983 G>T), a deletion of two nucleotides (1039¨C1040delTG), and the point mutations P86L, S201R, S492L, D949V and H978R [13]. The 85T>C mutation might be a common polymorphism, although functional analysis of a recombinantly expressed human protein carrying the 85T>C mutation showed no significant residual mutant enzyme activity [10,14]. An in-depth discussion of the clinical import of DPD can be found in a number of review articles, and two examples are provided in Refs. [37,38], which discuss the role of DPD in cancer therapy with 5FU |
» ²ÂÄãϲ»¶
07»¯Ñ§280·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
¿¼Ñл¯Ñ§308·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
070300»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
ÉúÎïѧһ־Ը985£¬·ÖÊý349Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
341Çóµ÷¼Á(Ò»Ö¾Ô¸ºþÄÏ´óѧ070300)
ÒѾÓÐ4È˻ظ´
336»¯¹¤µ÷¼Á
ÒѾÓÐ5È˻ظ´
279·ÖÇóµ÷¼Á Ò»Ö¾Ô¸211
ÒѾÓÐ17È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑоÀú
ÒѾÓÐ12È˻ظ´
Ò»Ö¾Ô¸ÉϺ£½»´óÉúÎïÓëҽҩר˶324·Ö£¬Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÉϺ£Õæ³ÏÍѵ¥£¬ÕâÊÇһƪºÜÈÏÕæµÄÏàÇ×Ìù£¬ÕÒÒ»¸öÁé»ê°éÂÂ
+1/170
ÇóÖú×ÏÍâ¿É¼û·Ö¹â¹â¶È¼Æ
+1/99
ÕÐÊÕ»¯Ñ§£¬²ÄÁÏ£¬»·¾³£¬»¯¹¤µÈרҵ»ù´¡µÄͬѧ¹¥¶Á˶ʿÑо¿Éú
+1/88
º£ÄÏ´óѧ»¯¹¤ÔºÉúÎïÖʶ¨Ïòת»¯¿ÎÌâ×éÕÐÊÕ²©Ê¿/˶ʿ£¬2026Äê9ÔÂÈëѧ
+1/81
Æ®ÔÚÃÀ¹ú£¬ÓеãÏë¼Ò
+1/51
½ËտƼ¼´óѧÄÜÔ´²ÄÁÏ»¯Ñ§¿ÎÌâ×é¹ùÐË÷½ÌÊÚÕÐÊÕ²©Ê¿Ñо¿Éú1-2Ãû
+1/43
ÕÐÊÕ2026Äê²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á£¬É½¶«Ê¡ÊôÖØµã´óѧ£¬¹ý¹ú¼ÒÏß¼´¿Éµ÷¼Á£¬Ãû¶î³ä×ã
+2/32
Öйú¿ÆÑ§Ôºº¼ÖÝҽѧÑо¿Ëùñû½½¿ÎÌâ×éÕÐÆ¸²©Ê¿ºó
+1/30
˫һÁ÷´óÑ§ÏæÌ¶´óѧ¡°»¯¹¤¹ý³ÌÄ£ÄâÓëÇ¿»¯¡±¹ú¼ÒµØ·½ÁªºÏ¹¤³ÌÑо¿ÖÐÐÄÕÐÊÕ¸÷À಩ʿÉú
+1/19
ÁÙÒÊ´óѧÊýѧÓëͳ¼ÆÑ§ÔºÕÐ2026Ñо¿Éú
+1/11
¡¾²©Ê¿ÕÐÉú¡¿ÉϺ£½»Í¨´óѧ³ÂÙ»èÝ¿ÎÌâ×éÕÐÊÕ2026ÄêÉêÇë-¿¼ºË²©Ê¿Éú1Ãû£¨ÄÜÔ´²ÄÁÏ·½Ïò£©
+1/8
Äþ²¨¶«·½Àí¹¤´óѧÓàÅô¿ÎÌâ×é2026ÄêÉϺ£½»´óÁªÅ಩ʿÉú¡¢²©Ê¿ºó¡¢¿ÆÑÐÖúÀíÕÐÆ¸
+1/7
ÉϺ£½»Í¨´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÅÖÇÌοÎÌâ×é³ÏƸ²©Ê¿ºó
+1/7
ÉϺ£½»´óÕÐÊÕ26Äê¼¶Çï¼¾Èëѧ²©Ê¿Éú£¬CET-6¹ý£¬ÉúÎïÒ½ÓòÄÁÏ·½Ïò£¨Óи߷Ö×Ӻϳɻù´¡£©
+1/5
Öйú¿ÆÑ§ÔºÉϺ£¹èËáÑÎÑо¿ËùÕÐÆ¸¿ÆÑÐÖúÀí
+1/4
CD8¿¹ÌåÈçºÎ½âÂëÖ×Áö½þÈóTϸ°û£¿
+1/3
Ìì½ò´óѧÀíѧԺ·ÖÀë·ÖÎö¼°¹¦ÄܲÄÁÏÑо¿×é
+1/2
Ïã¸ÛÖÐÎÄ´óѧ»¯Ñ§ÏµÎâ»ùÅà½ÌÊÚÕÐļ2026ÄêÇï¼¾£¨2026Äê8ÔÂ1ÈÕ£©Èëѧȫ½±²©Ê¿Ñо¿Éú
+1/2
´óÁ¬º£Ê´óѧ´¬²°½à¾»ÄÜÔ´Ñо¿ÖÐÐÄ2026Ä격ʿÑо¿ÉúÕÐÉúÆôÊÂ
+1/2
Õã½´óѧ¸ß´¿·ÖÀëÍÅ¶Ó³ÏÆ¸²©Ê¿ºó
+1/1
µØÍ¼ÎÏÅ£
Òø³æ (СÓÐÃûÆø)
- ·ÒëEPI: 9
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 339.4
- Ìû×Ó: 71
- ÔÚÏß: 16.5Сʱ
- ³æºÅ: 804596
ЦÊÀ¿ñÁú(½ð±Ò+25, ·ÒëEPI+1): ллÄã 2011-03-11 20:27:42
|
ÄúÊDz»ÊǰÑһƪDPDµÄ×ÛÊöÒ»µãµãÌùѽ¡£ ĿǰÒѱ¨µÀÓжà¸öÍ»±äµ¼ÖÂÍêÈ«¹¦ÄÜȱʧ£¬ÕâЩͻ±äÓУºÁ½¸öȱʧͻ±ä£¨295¨C298delTCAT and 1897delC£©£¬Ò»¸ö¼ô½ÓλµãÍ»±ä(IVS14+IG>A)£¬4¸ö´íÒåÍ»±ä(85T>C, 703C>T, 2657G>A, and 2983 G>T)£¬Ò»¸öÁ½¸öºËÜÕËáµÄȱʧͻ±ä(1039¨C1040delTG)ºÍ¼¸¸öµãÍ»±äP86L, S201R, S492L, D949V and H978R¡£85T>CÍ»±ä¿ÉÄÜÊÇÒ»¸ö±È½ÏÆÕ±éµÄ¶à̬ÐÔ£¬µ«Ð¯´ø85T>CÍ»±äµÄÖØ×éÈËDPDµ°°×²¢Ã»ÓÐÃ÷ÏÔµÄÍ»±äøµÄ»îÐÔ²ÐÓà¡£´óÁ¿×ÛÊöÒѾÉîÈëÌÖÂÛÁËDPDµÄÖØÒªÁÙ´²×÷Óã¬ÎÄÏ×37£¬38ÖоÍÓÐÁ½¸öÀý×Ó£¬ÕâÁ½Æª×ÛÊöÌÖÂÛÁËDPDÔÚ5FUÖÎÁư©Ö¢ÖеÄ×÷Óᣠ|
2Â¥2011-03-11 10:50:33
3Â¥2011-03-11 20:40:20













»Ø¸´´ËÂ¥